Woman's World on MSN

Blood in your urine? 5 bladder cancer symptoms you should never ignore

Nearly 20,000 women are diagnosed with bladder cancer each year, according to the American Cancer Society, with most being ...
Morningstar

Pfizer's Sasanlimab Hits Late-Stage Study Primary Endpoint for Bladder Cancer

Pfizer said a late-stage study of its sasanlimab drug candidate met its key goal in certain patients with bladder cancer. Pfizer on Friday said the pivotal Phase 3 study evaluating sasanlimab in ...
WebMD

Non-Muscle Invasive Bladder Cancer

Non-muscle invasive bladder cancer is cancer that’s only in the inner lining of your bladder. It hasn’t grown into the muscle wall. Your doctor may also call it superficial bladder cancer, urothelial ...

Pfizer, Astellas post late-stage trial win for Padcev in bladder cancer with Merck’s Keytruda

Pfizer (PFE) stock is in focus as the firm with Astellas (ALPMF) post a Phase 3 trial win for Padcev cancer drug when used with Merck's (MRK) Keytruda. Read more here.

Positive Phase 3 PADCEV–Keytruda Bladder Cancer Data Could Be A Game Changer For Astellas ...

In December 2025, Astellas Pharma and Pfizer reported that their Phase 3 EV-304 trial of PADCEV plus Keytruda in muscle-invasive bladder cancer achieved statistically significant improvements in event ...
Benzinga.com

CG Oncology Touts Encouraging Data From Late-Stage Study Of Bladder Cancer Candidate

On Thursday, CG Oncology, Inc. (NASDAQ:CGON) revealed topline data from the Phase 3 BOND-003 trial in patients with high-risk Non-Muscle Invasive Bladder Cancer (NMIBC) unresponsive to Bacillus ...